{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:40:02Z","timestamp":1790912402538,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004576","name":"Israel Ministry of Agriculture and Rural Development","doi-asserted-by":"publisher","award":["1211-0023"],"award-info":[{"award-number":["1211-0023"]}],"id":[{"id":"10.13039\/501100004576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126531","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:24:08Z","timestamp":1732296248000},"page":"126531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P2","title":["Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac\u00ae, Zoetis\u2122): Evaluation of dose-dependent effectiveness and long-term immunity"],"prefix":"10.1016","volume":"43","author":[{"given":"Dan","family":"Gleser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Kenigswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maor","family":"Kedmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Sharir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Klement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126531_bb0005","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1128\/JVI.02797-13","article-title":"Evolution of bovine ephemeral fever virus in the Australian Episystem","volume":"88","author":"Trinidad","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0010","first-page":"46","article-title":"Epidemiology and control of bovine ephemeral fever","author":"Walker","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2024.126531_bb0015","first-page":"11","article-title":"Bovine ephemeral fever in Asia: recent status and research gaps","author":"Lee","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126531_bb0020","series-title":"The Development of Dual Vaccines against Lumpy Skin Disease (LSD) and Bovine Ephemeral Fever (BEF)","author":"Douglass","year":"2021"},{"key":"10.1016\/j.vaccine.2024.126531_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0082217","article-title":"Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine","volume":"8","author":"Aziz-Boaron","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126531_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2014.06.021","article-title":"The protective effectiveness of an inactivated bovine ephemeral fever virus vaccine","volume":"173","author":"Aziz-Boaron","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/vr.117.2.37","article-title":"A bovine ephemeral fever vaccine incorporating adjuvant Quil a: a comparative study using adjuvants Quil a, aluminium hydroxide gel and dextran sulphate","volume":"117","author":"Vanselow","year":"1985","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2024.126531_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-1135(95)00077-N","article-title":"Field trials of ephemeral fever vaccines","volume":"46","author":"Vanselow","year":"1995","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2023.06.062","article-title":"Effectiveness of the strain 919 bovine ephemeral fever virus vaccine in the face of a real-world outbreak: a field study in Israeli dairy herds","author":"Gleser","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126531_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-6-174","article-title":"Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis a","volume":"6","author":"Srinivasa Rao","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126531_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-1135(95)00077-N","article-title":"Field trials of ephemeral fever vaccines","volume":"46","author":"Vanselow","year":"1995","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0060","author":"Ultravac"},{"key":"10.1016\/j.vaccine.2024.126531_bb0065","first-page":"11","article-title":"Wearable wireless biosensor Technology for Monitoring Cattle: a review","author":"Lee","year":"2021","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.vaccine.2024.126531_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.livsci.2020.104334","article-title":"Precision dairy monitoring technologies use in disease detection: differences in behavioral and physiological variables measured with precision dairy monitoring technologies between cows with or without metritis, hyperketonemia, and hypocalcemia","volume":"244","author":"Tsai","year":"2021","journal-title":"Livest Sci"},{"key":"10.1016\/j.vaccine.2024.126531_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2016.11.030","article-title":"High-resolution melting (HRM) for genotyping bovine ephemeral fever virus (BEFV)","volume":"229","author":"Erster","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.126531_bb0085","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.14202\/vetworld.2017.1367-1377","article-title":"Metabolic and immunological changes in transition dairy cows: a review","volume":"10","author":"Wankhade","year":"2017","journal-title":"Vet World"},{"key":"10.1016\/j.vaccine.2024.126531_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.prevetmed.2018.12.001","article-title":"Neethling vaccine proved highly effective in controlling lumpy skin disease epidemics in the Balkans","volume":"181","author":"Klement","year":"2020","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2024.126531_bb0095","series-title":"The survival package introduction","author":"Therneau","year":"2019"},{"key":"10.1016\/j.vaccine.2024.126531_bb0100","first-page":"13","article-title":"Reproducible summary tables with the gtsummary package","author":"Sjoberg","year":"2021","journal-title":"R Journal"},{"key":"10.1016\/j.vaccine.2024.126531_bb0105","series-title":"Dplyr: A grammar of data manipulation. R package version. Media","author":"Wickham","year":"2019"},{"key":"10.1016\/j.vaccine.2024.126531_bb0110","series-title":"coxme: Mixed Effects Cox Models. R package version 2.2\u201316. Cran","author":"Therneau","year":"2020"},{"key":"10.1016\/j.vaccine.2024.126531_bb0115","first-page":"1","article-title":"Package ggplot2: an implementation of the grammar of graphics","volume":"2","author":"Wickham","year":"2014","journal-title":"Create Elegant Data Visualisations Using the Grammar of Graphics"},{"key":"10.1016\/j.vaccine.2024.126531_bb0120","series-title":"R Package psych","author":"Revelle","year":"2016"},{"key":"10.1016\/j.vaccine.2024.126531_bb0125","article-title":"The caret package","author":"Irizarry","year":"2020","journal-title":"Introduction to Data Science"},{"key":"10.1016\/j.vaccine.2024.126531_bb0130","series-title":"R package diagram: Visualising simple graphs, flowcharts, and webs","author":"Soetaert","year":"2014"},{"key":"10.1016\/j.vaccine.2024.126531_bb0135","volume":"1","author":"KableExtra","year":"2019","journal-title":"Construct complex table with \u2018kable\u2019 and pipe syntax"},{"key":"10.1016\/j.vaccine.2024.126531_bb0140","series-title":"Package \u201cstats.\u201d","author":"Team","year":"2016"},{"key":"10.1016\/j.vaccine.2024.126531_bb0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.vaccine.2024.126531_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jcm12041633","article-title":"Simpson\u2019s paradox in clinical research: a cautionary tale","volume":"12","author":"Bonovas","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.vaccine.2024.126531_bb0155","first-page":"23","article-title":"Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study","author":"Chemaitelly","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126531_bb0160","first-page":"10","article-title":"Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US healthcare personnel, October 2021-July 2022","author":"Plumb","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126531_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074325","article-title":"Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses","author":"Andersson","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.126531_bb0170","first-page":"31","article-title":"Waning immunity to measles in young adults and booster effects of revaccination in secondary school students","author":"He","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126531_bb0175","first-page":"31","article-title":"The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease","author":"Elnekave","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126531_bb0180","first-page":"6","article-title":"Force of infection: a determinant of vaccine efficacy?","author":"Kaslow","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.126531_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.vetmic.2014.07.021","article-title":"Relationships of bovine ephemeral fever epizootics to population immunity and virus variation","volume":"173","author":"Ting","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0378-1135(79)90056-7","article-title":"An experimental inactivated virus vaccine against bovine ephemeral fever 2. Do neutralizing antibodies protect against infection?","volume":"4","author":"Della-Porta","year":"1979","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0195","first-page":"94","article-title":"Evaluation of antibody response to inactivated bovine ephemeral fever virus vaccine for Japanese black calves in the field","author":"Otomaru","year":"2023","journal-title":"Anim Sci J"},{"key":"10.1016\/j.vaccine.2024.126531_bb0200","first-page":"31","article-title":"The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease","author":"Elnekave","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126531_bb0205","first-page":"37","article-title":"Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis a vaccine","volume":"35","author":"Flehmig","year":"1997","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2024.126531_bb0210","first-page":"24","article-title":"Effectiveness of the booster dose of inactivated COVID-19 vaccine against omicron BA.5 infection: a matched cohort study of adult close contacts","author":"Zeng","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.vaccine.2024.126531_bb0215","first-page":"11","article-title":"Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study. Emerg","author":"Sritipsukho","year":"2022","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.126531_bb0220","first-page":"37","article-title":"Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis","author":"Law","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2024.126531_bb0225","first-page":"11","article-title":"Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 omicron variant escape from neutralizing antibodies. Emerg","author":"Wang","year":"2022","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.126531_bb0230","first-page":"85","article-title":"Antibody efficacy of inactivated vaccine boosters (CoronaVac) against omicron variant from a 15-month follow-up study","author":"Yin","year":"2022","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2024.126531_bb0235","first-page":"34","article-title":"Target trial emulation to improve causal inference from observational data: what, why, and how?","author":"Fu","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071108","article-title":"Target trial emulation: applying principles of randomised trials to observational studies","author":"Matthews","year":"2022","journal-title":"The BMJ"},{"key":"10.1016\/j.vaccine.2024.126531_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126531_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cvfa.2007.11.001","article-title":"Neonatal immune development in the calf and its impact on vaccine response","volume":"24","author":"Chase","year":"2008","journal-title":"Vet Clin N Am Food Anim Pract"},{"key":"10.1016\/j.vaccine.2024.126531_bb0255","series-title":"Genetic instability of RNA viruses","author":"Barr","year":"2016"},{"key":"10.1016\/j.vaccine.2024.126531_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/v16030479","article-title":"Predicting vaccine effectiveness for hospitalization and symptomatic disease for novel SARS-CoV-2 variants using neutralizing antibody titers","volume":"16","author":"Gardner","year":"2024","journal-title":"Viruses"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T03:21:47Z","timestamp":1734492107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0264410X24012131"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126531","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac\u00ae, Zoetis\u2122): Evaluation of dose-dependent effectiveness and long-term immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126531"}}